Ainos Corp (AIMD): Net earnings per share (EPS TTM)

Graphic logo of Ainos Corp (AIMD)

Ainos, Inc. (AIMD) is expanding its margins through scalable testing systems and IT integrations, offsetting R&D expenses. The annual net income per share trend illustrates the market reaction, where the value of -2.53 corresponds to the current metric. The company is implementing sensory breath diagnostics for real-time health monitoring while simultaneously minimizing plastic use and safely disposing of chemicals in production.

AIMD Ainos Corporation Net earnings per share for the last four quarters (04/28/2023 - 11/16/2026)

Metric breakdowns and analytics for Ainos Corporation (AIMD)

- current quotes and average value forecast:
- stock exchange capitalization data:
Fundamental valuation:AIMD - Ainos Corporation
Manufactured products of Ainos Corp

Ainos, Inc. is scaling express diagnostics by integrating medical systems into cloud-based telemedicine services. This metric measures net income allocated per common share per year, reflecting the actual efficiency of capital management. Analyzing the earnings per share trend over the last 12 months allows for an assessment of business sustainability regardless of issuance. Stable growth of the line confirms the company's fundamental strength. However, purchasing the asset at a local maximum increases the risk of a price correction.

Main competitors

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months